Evaluate Ovulation and PK of Medroxyprogesterone Acetate Following Dose of TV-46046
- Study Title
- Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
- Teva Identifier
- TV46046-WH-10075
- ClinicalTrials.gov Identifier
- NCT02817464
- Study Status
- Completed
- Trial Condition(s)
- Pregnancy | Contraception
- Interventions
- Drug: TV-46046 - 400 mg/mL | Drug: TV-46046 - 200 mg/mL | Drug: TV-46046 - 300 mg/mL (if warranted)
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 40 Years
- Trial Duration
- October 7, 2016 - December 3, 2018
- Phase
- Phase 1
